Stay updated on Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial

Sign up to get notified when there's something new on the Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3, indicating a new release.
    Difference
    0.0%
    Check dated 2024-09-04T08:56:46.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    New study sites have been added in multiple locations including Bellevue, Washington; Guangzhou and Nanjing in China; Zagreb, Croatia; Tokyo, Japan; Amsterdam, Netherlands; and Ankara, Turkey, while a previous study site has been removed.
    Difference
    2%
    Check dated 2024-08-28T06:49:25.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The study has expanded to include new recruiting sites in multiple countries, notably adding locations in Italy, China, and Japan, while removing previous sites in Japan and Taiwan.
    Difference
    3%
    Check dated 2024-08-21T06:02:14.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The study has expanded to include 152 locations, with new sites added in Argentina, China, Greece, Israel, Italy, and Portugal, while some previous locations and contact numbers have been removed.
    Difference
    2%
    Check dated 2024-08-14T05:29:59.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The study has increased from 136 to 144 participants, with new recruiting sites added in China, Greece, Italy, Japan, Poland, and Portugal, while the Tokyo site has been removed.
    Difference
    5%
    Check dated 2024-08-07T04:55:31.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The study has added several new recruiting sites in China, Greece, Japan, the Netherlands, and Taiwan, increasing the total number of sites from 128 to 136, with the latest update posted on July 30, 2024.
    Difference
    2%
    Check dated 2024-07-31T04:02:06.000Z thumbnail image

Stay in the know with updates to Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial page.